Everolimus 159351-69-6

Category :	Intermediates/Pharmaceutical intermediates
CAS NO :	159351-69-6
EC NO :
MF :	C₅₃H₈₃NO₁₄
MW :	958.2244
Packing :	5mg
Uses :	In the past, it was mainly used to prevent rejection after kidney transplantation and heart transplantation. It is also currently available for the treatment of patients with advanced renal cancer who have used two Chemicalbook formulations that inhibit V
Synonyms :	42-O-(2-Hydroxyethyl)-rapamycin;Certica;RAD-001;SDZRAD;Rapamycin, 42-O-(2-hydroxyethyl)-;Certican;CERTICAN(R);(3S,6R,7Z,9R,10R,12R,14S,15E,17Z,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;
Molecular Structure :

Everolimus

* Is Required Please send your Enquiry here:

Subject :	*
CAS NO :
Message :	*

Please check your contact information:

Company Name :	*
Your Name :	*
Tel :
Email :	* (type:abc@chemnet.com)